stockportfolio.pro
Stocks / ABSI vs AORT
ABSI vs AORT
Absci Corporation and Artivion, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Absci Corporation (ABSI) | Artivion, Inc. (AORT) | |
|---|---|---|
| Market cap | $1.0B | $1.0B |
| Revenue (latest FY) | $2.80M | $441.33M |
| Net income (latest FY) | $-115.18M | $9.77M |
| Revenue growth (5y CAGR) | -10.1% | 11.8% |
| Net margin | -4113.7% | 2.2% |
| Return on equity | -60.8% | 2.2% |
| P/E ratio | — | 82.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 4 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ABSI — free Open AORT — freeFrequently asked questions
Which is bigger, ABSI or AORT?
Artivion, Inc. is larger by market capitalization — $1.0B versus $1.0B.
Which grows faster, ABSI or AORT?
Over the last five fiscal years, Artivion, Inc. grew revenue faster — 11.8%/yr versus -10.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.